ADMA BIOLOGICS, INC. (ADMA) Net margin 2016–2025
ADMA BIOLOGICS, INC. (ADMA) net profit margin by fiscal year — reported net income divided by reported revenue.
28.8%FY2025 · since FY2016: -183.1% → 28.8%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 28.8% | -17.6 pp |
| FY2024 | 46.4% | +57.3 pp |
| FY2023 | -10.9% | +31.8 pp |
| FY2022 | -42.8% | +45.7 pp |
| FY2021 | -88.5% | +90.9 pp |
| FY2020 | -179.4% | -14.9 pp |
| FY2019 | -164.5% | +222.6 pp |
| FY2018 | -387.1% | -194.8 pp |
| FY2017 | -192.3% | -9.2 pp |
| FY2016 | -183.1% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice